Case Report: Rare gastric and bone metastases after early endocrine therapy discontinuation in hormone receptor-positive breast cancer: lessons and therapeutic insights
{{output}}
Breast cancer with gastric metastasis is extremely rare. Non-persistence with adjuvant endocrine therapy is associated with increased recurrence/metastasis risk in hormone receptor-positive (HR+) breast cancer. A 33-year-old female was initially diagnosed with... ...
